ARCHIVES

Navelbine+Herceptin: 78% Response In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

House Committee Seeks Information on ImClone Insider Stock Trading.

March 29, 2002

FDA Designates Zometa For Priority Review.

November 30, 2001

ASCO Breaks Ground For New HQ.

August 4, 2006

In Brief” McKenna New ACS President, Lemaistre President Elect; Michael Potter Wins Albert Lasker Award

November 23, 1984

ACS Increases Funding for Scholar Grants; NCI Posts Interim FY2001 Funding Policy.

December 1, 2000